Acer Therapeutics Inc ACER:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/20/22 EDT
2.19quote price arrow up+0.06 (+2.82%)
Volume
60,248
52 week range
1.68 - 3.77
Loading...
  • Open2.13
  • Day High2.21
  • Day Low2.06
  • Prev Close2.13
  • 52 Week High3.77
  • 52 Week High Date04/04/22
  • 52 Week Low1.68
  • 52 Week Low Date12/06/21

Key Stats

  • Market Cap38.96M
  • Shares Out17.79M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change-3.95

KEY STATS

  • Open2.13
  • Day High2.21
  • Day Low2.06
  • Prev Close2.13
  • 52 Week High3.77
  • 52 Week High Date04/04/22
  • 52 Week Low1.68
  • 52 Week Low Date12/06/21
  • Market Cap38.96M
  • Shares Out17.79M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change-3.95

RATIOS/PROFITABILITY

  • EPS (TTM)-1.08
  • P/E (TTM)-2.03
  • Fwd P/E (NTM)-0.95
  • EBITDA (TTM)-15.877M
  • ROE (TTM)-472.99%
  • Revenue (TTM)1.26M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-1,220.16%
  • Debt To Equity (MRQ)-0.00%

EVENTS

  • Earnings Date08/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acer Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Acer Therapeutics Inc. is a pharmaceutical company, which is focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs. The Company’s pipeline includes four programs: ACER-001 (sodium phenylbutyrate), ACER-801 (osanetant), EDSIVO (celiprolol) and ACER-2820 (emetine). ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle...
Stephen Aselage
Independent Chairman of the Board
Christopher Schelling
President, Chief Executive Officer, Director
Harry Palmin
Chief Financial Officer, Chief Operating Officer
Address
One Gateway Center (300 Washington St.)
Suite 356
Newton, MA
02458
United States

Top Peers

SYMBOLLASTCHG%CHG
CRBP
Corbus Pharmaceuticals Holdings Inc
0.341-0.0067-1.9269%
ONCS
OncoSec Medical Inc
0.77+0.03+4.05%
CLBS
Caladrius Biosciences Inc
0.4615UNCHUNCH
PCSA
Processa Pharmaceuticals Inc
2.46+0.21+9.33%
ADIL
Adial Pharmaceuticals Inc
1.36-0.01-0.73%